AIMS: The NCDR ACTION Registry-GWTG collects detailed in-hospital clinical, process-of-care and outcomes data for patients admitted with acute myocardial infarction (AMI) in the USA. The registry is a national AMI surveillance system that contributes to the scientific enquiry process of AMI care through the facilitation of local and national quality improvement efforts. INTERVENTIONS: No treatments are mandated, participating centres receive routine quality-of-care and outcomes performance feedback reports and access to quality of care tools, such as dosing algorithms and standing orders. POPULATION: AMI patients are retrospectively identified. No informed consent is required, as data are anonymised. From January 2007 to date, 147 165 records have been submitted from 383 participating US hospitals. Patients with a primary diagnosis of ST-segment elevation myocardial infarction or non-ST-segment elevation myocardial infarction are eligible for enrolment in the registry. These patients must have ischemic symptoms and electrocardiogram changes, and/or positive cardiac markers within 24 hours of initial presentation. BASELINE DATA: Approximately 350 fields encompassing patient demographics, medical history and risk factors, hospital presentation, initial cardiac status, medications and associated doses, reperfusion strategy, procedures, laboratory values, and outcomes. Data are manually entered by study personnel; there are non-financial incentives at the hospital level. Completeness within the registry is noteworthy with most fields at less than 5% missing. ENDPOINTS: Main outcome measures include American College of Cardiology/American Heart Association myocardial infarction performance indicators, as well as in-hospital patient outcomes. Data are available for research by application to: http://www.ncdr.com.
AIMS: The NCDR ACTION Registry-GWTG collects detailed in-hospital clinical, process-of-care and outcomes data for patients admitted with acute myocardial infarction (AMI) in the USA. The registry is a national AMI surveillance system that contributes to the scientific enquiry process of AMI care through the facilitation of local and national quality improvement efforts. INTERVENTIONS: No treatments are mandated, participating centres receive routine quality-of-care and outcomes performance feedback reports and access to quality of care tools, such as dosing algorithms and standing orders. POPULATION: AMI patients are retrospectively identified. No informed consent is required, as data are anonymised. From January 2007 to date, 147 165 records have been submitted from 383 participating US hospitals. Patients with a primary diagnosis of ST-segment elevation myocardial infarction or non-ST-segment elevation myocardial infarction are eligible for enrolment in the registry. These patients must have ischemic symptoms and electrocardiogram changes, and/or positive cardiac markers within 24 hours of initial presentation. BASELINE DATA: Approximately 350 fields encompassing patient demographics, medical history and risk factors, hospital presentation, initial cardiac status, medications and associated doses, reperfusion strategy, procedures, laboratory values, and outcomes. Data are manually entered by study personnel; there are non-financial incentives at the hospital level. Completeness within the registry is noteworthy with most fields at less than 5% missing. ENDPOINTS: Main outcome measures include American College of Cardiology/American Heart Association myocardial infarction performance indicators, as well as in-hospital patient outcomes. Data are available for research by application to: http://www.ncdr.com.
Authors: Raina M Merchant; Lin Yang; Lance B Becker; Robert A Berg; Vinay Nadkarni; Graham Nichol; Brendan G Carr; Nandita Mitra; Steven M Bradley; Benjamin S Abella; Peter W Groeneveld Journal: Crit Care Med Date: 2011-11 Impact factor: 7.598
Authors: Christopher M Gamboa; Monika M Safford; Emily B Levitan; Devin M Mann; Huifeng Yun; Stephen P Glasser; J Michael Woolley; Robert Rosenson; Michael Farkouh; Paul Muntner Journal: Am J Med Sci Date: 2014-08 Impact factor: 2.378
Authors: Adam B Landman; Erica S Spatz; Emily J Cherlin; Harlan M Krumholz; Elizabeth H Bradley; Leslie A Curry Journal: Ann Emerg Med Date: 2012-11-10 Impact factor: 5.721
Authors: Neal A Chatterjee; M Vinayaga Moorthy; Julie Pester; Andi Schaecter; Gopi K Panicker; Dhiraj Narula; Daniel C Lee; Jeffrey J Goldberger; Alan Kadish; Nancy R Cook; Christine M Albert Journal: JAMA Cardiol Date: 2018-07-01 Impact factor: 14.676
Authors: Sandeep R Das; Karen P Alexander; Anita Y Chen; Tiffany M Powell-Wiley; Deborah B Diercks; Eric D Peterson; Matthew T Roe; James A de Lemos Journal: J Am Coll Cardiol Date: 2011-12-13 Impact factor: 24.094
Authors: Vinay Kini; Pamela N Peterson; John A Spertus; Kevin F Kennedy; Suzanne V Arnold; Jason H Wasfy; Jeptha P Curtis; Steven M Bradley; Amit P Amin; P Michael Ho; Frederick A Masoudi Journal: Circ Cardiovasc Qual Outcomes Date: 2018-10
Authors: Jason H Wasfy; Kevin F Kennedy; Frederick A Masoudi; Timothy G Ferris; Suzanne V Arnold; Vinay Kini; Pamela Peterson; Jeptha P Curtis; Amit P Amin; Steven M Bradley; William J French; John Messenger; P Michael Ho; John A Spertus Journal: Circ Cardiovasc Qual Outcomes Date: 2018-09
Authors: Deborah B Diercks; Michael C Kontos; Judd E Hollander; Bryn E Mumma; DaJuanicia N Holmes; Stephen Wiviott; Jorge F Saucedo; James A de Lemos Journal: Am J Emerg Med Date: 2013-05-20 Impact factor: 2.469
Authors: Shukri M Al-Saif; Khalid F Alhabib; Anhar Ullah; Ahmed Hersi; Husam Alfaleh; Khalid Alnemer; Amir Tarabin; Ahmed Abuosa; Tarek Kashour; Mushabab Al-Murayeh Journal: J Saudi Heart Assoc Date: 2011-10-19